Ana ba da umarnin Methotrexate don magance cututtuka na rheumatoid da sauran ka'idodin rheumatic. Ana kwatanta Methotrexate a matsayin magungunan anti-rheumatic na gyaran cutar (DMARD). Da miyagun ƙwayoyi yana rage ciwo da ƙumburi da ke haɗuwa da cututtukan arthritis na rheumatoid, yana jinkirin ci gaba da cutar, kuma yana taimakawa hana lalacewar haɗuwa. A lokacin da la'akari da tasiri da aminci, inganci ne mafi kyau fiye da na bin hanya?
Availability
Oral methotrexate yana samuwa a 2.5 MG allunan. Halin farawa na farko ga manya da cututtuka na rheumatoid na 7.5 zuwa 10 MG (3 zuwa 4 kwayoyi) hade tare sau ɗaya a mako. Idan an buƙata, za a iya ɗaukar kashi a hankali zuwa 20 zuwa 25 MG a mako. Kwararku zai ƙayyade ainihin kashi a gare ku.
An ba da allurar Methotrexate karkashin fata (subcutaneously). Ya zo kamar 25 MG da 1 milliliter ko cubic centimeter. Bugu da ƙari, likitanku zai rubuta ƙimar da ya kamata ku yi amfani da shi. A cikin yara tare da ƙwayar ƙwayar cuta na yara, kashi yana dogara ne akan nauyin yaron.
Wace irin Fassara ne ake so?
Anyi amfani da allurar gyaran gyaran ƙwayar ƙarancin marasa lafiya da yawa yayin da aka kwatanta da tsarin hanya. Sayen shinge da kuma jingine kanka da allura a kowane mako zai iya zama matsala. Wasu mutane ne ainihin needle-phobic. Don haka, me ya sa kuke damuwa lokacin da za ku iya fitar da kwayoyi?
Mene ne idan akwai bambanci a tsakanin methotrexate allura da kuma na baka methotrexate a cikin sharuddan tasiri da kuma hadarin sakamako na illa?
Bisa ga sakamakon binciken daga farkon gwaji na asibitoci don bincikar tsarin binciken mafi kyau a cikin marasa lafiya da cututtuka na rheumatoid, wanda aka wallafa shi a cikin Janairu 2008 na Arthritis & Rheumatism, injection methode (wanda ake kira subcutaneous methotrexate) yana da muhimmanci mafi tasiri fiye da na baka Gudanar da tsarin daidaitawa a daidai wannan sashi, ba tare da karuwa a sakamakon illa ba.
Akwai kimanin mutane 384 masu nazari a cikin binciken makonni 24 da aka ba da izinin yin amfani da su ta hanya ko kuma hanya ta hanyar magana. Mahalarta masu binciken, sun ce suna da babban cututtuka a farkon binciken, sun sami maganin mako-mako na methotrexate mako-mako tare da guraben giraben maganganu 15 mg ko'ina mako daya da kuma allurar wuri.
Daga binciken binciken, masu bincike sun yanke shawarar yin amfani da allurar rigakafi, ta hanyar amfani da sashi na 15 MG / mako na tsawon makonni 24 (ciki har da yiwuwar haɓaka), yana da kyau ga farawa hanya ta hanya ta hanya. A makonni 24, adadin marasa lafiya tare da amsa ACR20 sun fi girma a cikin rukunin da ke karɓar maganin (78%) a cikin rukunin karbaccen hanya (70%).
Methotrexate mai hankali ne
Tare da yin amfani da hanzari, ingantaccen cututtukan cututtuka na arthritis ko cututtukan cututtuka na yawanci ana gano su cikin makonni 3 zuwa 6. Zai iya ɗaukar makonni 12 na jiyya tare da bin hanya don cimma cikakken amfani.
Hanyoyin Gaba
Yawancin marasa lafiya na cututtukan ƙwayoyin cuta ba su da kwarewa a duk lokacin da suke bin hanya. Wasu marasa lafiya suna fama da ƙananan cututtuka da suka inganta fiye da lokaci.
Mafi rinjaye na gaba na hanya shi ne tashin hankali.
Sauran cututtukan lalacewa na iya haɗawa da gwaje-gwajen haɗarin hanta , bakin ciki , rash, zawo, raunin gashi , hasken rana , da kuma rashin haɗari a cikin jini. Akwai matsala ga matsalolin huhu.
Sources:
Methotrexate (Rheumatrex, Trexall, Otrexup, Rasuvo). Kwalejin Amirka na Rheumatology. Michael Cannon, MD. Maris 2015.
Daidaita ƙwarewar asibiti da inganci na cututtuka ta hanyar magance ta hanyar yin amfani da hanzari a cikin marasa lafiya tare da ciwon maganin rheumatoid. Braun et al. Arthritis & Rheumatism Volume 58, Issue 1, Shafuka 73-81. Disamba 28, 2007.